P561. Time course and clinical implications of development of binding and neutralizing antibodies against adalimumab in patients with inflammatory bowel disease
2015 ◽
Vol 9
(suppl 1)
◽
pp. S360-S361
◽
2016 ◽
Vol 50
(6)
◽
pp. 483-489
◽
Keyword(s):
2021 ◽
Vol 55
(2)
◽
pp. 83-93
2012 ◽
Vol 18
(12)
◽
pp. 2209-2217
◽
Keyword(s):
2003 ◽
Vol 17
(1)
◽
pp. 3-18
◽
2016 ◽
Vol 52
(3)
◽
pp. 344-350
◽
Keyword(s):
Enteric bacterial proteases in inflammatory bowel disease- pathophysiology and clinical implications
2013 ◽
Vol 19
(43)
◽
pp. 7531
◽
2019 ◽
Vol 47
◽
pp. 102189
◽
Keyword(s):
2008 ◽
Vol 100
(6)
◽
pp. 798-802
◽